$BGNE with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $BGNE after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 66.67%.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.79CNY
−6.25 BCNY
17.42 BCNY
115.06 M
About BEIGENE, LTD.
Sector
CEO
John V. Oyler
Headquarters
George Town
Website
Founded
2010
ISIN
CNE100005XT6
FIGI
BBG00Z3T2MQ6
BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
$BGNE with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BGNE after a Negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 80%.
$BGNE with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BGNE after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 100%.
#6160 pull-back and hits support line $213.6 Hi Everybody
#6160 pull-back and hits support line $213.6, expects to test the BLUE LINES, and stops if closes below the RED line.
BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA BGNE: BeiGene, Ltd.
2021-07-29 20:00:00
BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
BGNE short above 260$, target price 161$, about Mar 9, 2021.BGNE short above 260$, target price 161$, about Mar 9, 2021.
Similar pattern of Aug 8, 2018.
Wait BGNE price reached 161$, start building long position.
It's not a good idea holding BGNE under 270$~260$
Long stop-Loss price : 259$
Short stop-loss price : 284$
BGNE: Long strategy after gap overlapWe will trade long in the range $140 - 150 amid to gap overlap. Target will be $190 / 200. (+30% potentially)
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 688235 is featured.
Frequently Asked Questions
The current price of 688235 is 167.10 CNY — it has decreased by −3.73% in the past 24 hours. Watch BEIGENE, LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange BEIGENE, LTD. stocks are traded under the ticker 688235.
688235 stock has fallen by −7.17% compared to the previous week, the month change is a 1.69% rise, over the last year BEIGENE, LTD. has showed a 12.96% increase.
We've gathered analysts' opinions on BEIGENE, LTD. future price: according to them, 688235 price has a max estimate of 206.62 CNY and a min estimate of 88.87 CNY. Watch 688235 chart and read a more detailed BEIGENE, LTD. stock forecast: see what analysts think of BEIGENE, LTD. and suggest that you do with its stocks.
688235 reached its all-time high on Oct 8, 2024 with the price of 207.98 CNY, and its all-time low was 82.00 CNY and was reached on Apr 27, 2022. View more price dynamics on 688235 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688235 stock is 4.47% volatile and has beta coefficient of 0.88. Track BEIGENE, LTD. stock price on the chart and check out the list of the most volatile stocks — is BEIGENE, LTD. there?
Today BEIGENE, LTD. has the market capitalization of 239.63 B, it has decreased by −1.48% over the last week.
Yes, you can track BEIGENE, LTD. financials in yearly and quarterly reports right on TradingView.
BEIGENE, LTD. is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
688235 earnings for the last quarter are −0.69 CNY per share, whereas the estimation was −1.32 CNY resulting in a 47.80% surprise. The estimated earnings for the next quarter are −0.62 CNY per share. See more details about BEIGENE, LTD. earnings.
BEIGENE, LTD. revenue for the last quarter amounts to 6.67 B CNY, despite the estimated figure of 5.87 B CNY. In the next quarter, revenue is expected to reach 6.93 B CNY.
688235 net income for the last quarter is −872.01 M CNY, while the quarter before that showed −1.81 B CNY of net income which accounts for 51.70% change. Track more BEIGENE, LTD. financial stats to get the full picture.
No, 688235 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 1, 2024, the company has 10.00 K employees. See our rating of the largest employees — is BEIGENE, LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BEIGENE, LTD. EBITDA is −5.71 B CNY, and current EBITDA margin is −45.55%. See more stats in BEIGENE, LTD. financial statements.
Like other stocks, 688235 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEIGENE, LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BEIGENE, LTD. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BEIGENE, LTD. stock shows the buy signal. See more of BEIGENE, LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.